-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Optimizing Diagnostic Approaches for von Willebrand Disease

PhD Trainee  Ticketed Session
Program: How I Treat: Bringing Science to Clinical Dilemmas
Sunday, December 6, 2015: 11:15 AM-12:15 PM
Bayhill 18 (Hyatt Regency Orlando)
Speaker:
Paula D. James, MD, Queen's University

Disclosures:
James: Biogen Idec: Honoraria ; Octapharma: Honoraria , Research Funding ; Baxter: Honoraria ; CSL Behring: Honoraria , Research Funding ; Bayer: Honoraria , Research Funding .
See more of: How I Treat: Bringing Science to Clinical Dilemmas
<< Previous Session | Next Session >>